FDA Clearance Tracker · P160017-S020
MiniMed 670G System
Last checked: Nov 20, 2026Latest source record: Dec 8, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Dec 8, 2017
Approved
Time to decision
72 days
Received Sep 27, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P160017-S020
- Device name
- MiniMed 670G System
- Applicant
- Medtronic Minimed, Inc.
- Applicant location
- Northridge, CA
- Received
- Sep 27, 2017
- Decided
- Dec 8, 2017
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P160017
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for 1) minor design changes to the electronics board stack used in the 670G insulin pump; 2) a new supplier for the electronics board stack; 3) an updated pump software version; and 4) an extension to the 670G insulin pump shelf life from 185 days to 1095 days.
Source documents
Other decisions for Medtronic Minimed, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- MiniMed Flex pump510(k)
K253743 · Decided Mar 12, 2026 · 108 days after receipt
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG) · Laboratory Medicine & Pathology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.